Live Breaking News & Updates on Director Redmile Group

Stay updated with breaking news from Director redmile group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Absci (NASDAQ:ABSI) Announces Quarterly Earnings Results, Misses Estimates By $0.02 EPS

Absci (NASDAQ:ABSI – Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.02), Yahoo Finance reports. The firm had revenue of $0.34 million for the quarter, compared to analyst estimates of $1.75 million. Absci had a […] ....

Nova Scotia , United States , British Columbia , Redmile Group Llc , Jacobs Levy Equity Management Inc , Blackrock Inc , Securities Exchange Commission , Absci Corporation , Renaissance Technologies , Vanguard Group Inc , Absci Company Profile , Get Free Report , Yahoo Finance , Director Redmile Group , Exchange Commission , Street Corp , Jacobs Levy Equity Management , Absci Daily ,

Dimension Capital Management LLC Buys Shares of 21,584 Absci Co. (NASDAQ:ABSI)

Dimension Capital Management LLC Buys Shares of 21,584 Absci Co. (NASDAQ:ABSI)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , British Columbia , Exchange Commission , Jpmorgan Chase Co , Metlife Investment Management , Redmile Group Llc , Absci Corporation , Absci Co , Dimension Capital Management , Life Insurance Co , York Mellon Corp , Free Report , New York Mellon Corp , Life Investment Management , Rhumbline Advisers , Director Redmile Group , Truist Financial , Visit Holdingschannel , Absci Daily ,

Fate Therapeutics (NASDAQ:FATE) Issues Quarterly Earnings Results

Fate Therapeutics (NASDAQ:FATE – Get Free Report) announced its quarterly earnings data on Monday. The biopharmaceutical company reported ($0.45) earnings per share for the quarter, beating the consensus estimate of ($0.57) by $0.12, MarketWatch Earnings reports. Fate Therapeutics had a negative return on equity of 36.63% and a negative net margin of 253.30%. The company […] ....

Bahram Valamehr , Vanguard Group Inc , Fate Therapeutics Company Profile , Morgan Stanley , Blackrock Inc , Securities Exchange Commission , Redmile Group Llc , Wells Fargo Company , Fate Therapeutics Inc , Pricet Rowe Associates Inc , Fate Therapeutics , Get Free Report , Marketwatch Earnings , Therapeutics Trading Down , Director Redmile Group , Exchange Commission , Street Corp , Capital World Investors , World Investors , Wells Fargo , Fate Therapeutics Daily ,

Fate Therapeutics (NASDAQ:FATE) Releases Earnings Results, Beats Expectations By $0.12 EPS

Fate Therapeutics (NASDAQ:FATE – Get Free Report) released its earnings results on Monday. The biopharmaceutical company reported ($0.45) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.57) by $0.12, MarketWatch Earnings reports. Fate Therapeutics had a negative return on equity of 36.63% and a negative net margin of 253.30%. The firm […] ....

Bahram Valamehr , Voya Investment Management , Nuveen Asset Management , Barclays Plc , Wells Fargo Company , Redmile Group Llc , Fate Therapeutics Inc , Royal Bank , Fate Therapeutics Company Profile , Fate Therapeutics , Get Free Report , Marketwatch Earnings , Director Redmile Group , Investment Management , Asset Management , Howard Capital Management , Fate Therapeutics Daily ,

Fate Therapeutics (NASDAQ:FATE) Given New $7.00 Price Target at Wedbush

Fate Therapeutics (NASDAQ:FATE) Given New $7.00 Price Target at Wedbush
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Ceoj Scott Wolchko , National Bank , Fate Therapeutics Inc , Simplicity Solutions , Redmile Group Llc , Wells Fargo Company , Vanguard Personalized Indexing Management , Morgan Stanley , Fate Therapeutics , Get Free Report , Therapeutics Stock Down , Scott Wolchko , Director Redmile Group , Fate Therapeutics Daily ,